StockData
Nexentis Technologies Inc. logo

Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 2/30
$0.64−0.00 (-0.73%)

Close on Oct 19, 2026Market cap $522.65KP/E –Yield –

Nexentis Technologies gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Nexentis Technologies's gross profit for the twelve months ending Sep 30, 2025 was $136.00K, up 70.8% year over year. For fiscal 2024 it was $45.00K, down 78.4% from the year before. The highest annual figure on record is $315.50K in fiscal 2018.

Annual gross profit

PeriodPeriod endValueChange
FY2024Dec 31, 2024$45.00K-78.4%
FY2023Dec 31, 2023$208.00K-11.7%
FY2022Dec 31, 2022$235.69K-22.0%
FY2021Dec 31, 2021$302.20K+60.0%
FY2020Dec 31, 2020$188.87K+503.9%
FY2019Dec 31, 2019$31.28K-90.1%
FY2018Dec 31, 2018$315.50K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025-$2.00K-118.2%
Q1 FY2025Mar 31, 2025$52.00K+225.0%
Q4 FY2024Dec 31, 2024$86.00K-28.7%
Q3 FY2024Sep 30, 2024-$68.00K–
Q2 FY2024Jun 30, 2024$11.00K+14.6%
Q1 FY2024Mar 31, 2024$16.00K-79.6%
Q4 FY2023Dec 31, 2023$120.61K-16.8%
Q3 FY2023Sep 30, 2023-$476-101.8%
Q2 FY2023Jun 30, 2023$9.60K-46.9%
Q1 FY2023Mar 31, 2023$78.26K+71.0%
Q4 FY2022Dec 31, 2022$145.00K+19.5%
Q3 FY2022Sep 30, 2022$26.83K+51.4%
Q2 FY2022Jun 30, 2022$18.08K-58.0%
Q1 FY2022Mar 31, 2022$45.78K-61.9%
Q4 FY2021Dec 31, 2021$121.29K-19.7%
Q3 FY2021Sep 30, 2021$17.72K–
Q2 FY2021Jun 30, 2021$43.05K–
Q1 FY2021Mar 31, 2021$120.14K+180.8%
Q4 FY2020Dec 31, 2020$150.99K+26067.9%
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020-$4.91K–
Q1 FY2020Mar 31, 2020$42.79K-55.3%
Q4 FY2019Dec 31, 2019$577–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019-$64.99K–
Q1 FY2019Mar 31, 2019$95.69K–

More Nexentis Technologies figures

See a number that looks wrong?